Considerations when developing diagnostic assays using leading-edge technologies
23 March 2022

Given the power and potential of molecular IVDs, it is not surprising that in recent years clinical laboratories have seen significant growth in the available menu of tests based upon DNA and RNA analysis. In this white paper, Merck outlines the considerations you must take whilst developing new diagnostic assays.